» Articles » PMID: 29221207

Mutation Screening and Endoplasmatic Reticulum Stress in Macular Corneal Dystrophy

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Dec 10
PMID 29221207
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Macular corneal dystrophy (MCD) is an autosomal recessive disorder mainly caused by gene mutations of carbohydrate sulfotransferase () leading to bilateral visual impairment. Because the mechanism underlying this degeneration remains poorly understood, we investigated molecular alterations and pathways that may be involved in MCD in this issue. Different mutation sites were screened by direct sequencing of the coding region of . In addition, we described morphological changes in MCD keratocytes by light microscopy and electron microscopy and determined the relationship between the development of this disease and the occurrence of apoptosis through flow cytometry, cell counting kit-8, colony formation assay and other experiments. Western blotting and quantitative real-time polymerase chain reaction were used to determine if endoplasmic reticulum (ER) stress was activated. We found 10 kinds of mutations among these families with 3 novel mutations included. The percentage of apoptotic keratocytes increased in MCD patients; furthermore, the expression of apoptosis related protein B-cell lymphoma-2 (Bcl-2) was down-regulated while Bcl-2 associated X protein was upregulated. Finally, ER stress was activated with the upregulation of glucose-regulated protein 78 and CCAAT-enhancer-binding protein homologous protein. Our clinical and results suggest that the mutation associated with MCD is associated with apoptosis, and ER stress is probably involved in this apoptosis pathway.

Citing Articles

Genetic implications of CHST6 gene mutations and their corneal microstructural changes in macular corneal dystrophy patients.

Murugan D, Duvesh R, Adsumilli S, Prajna N, Chermakani P, Sundaresan P Mol Vis. 2025; 30:305-318.

PMID: 39959172 PMC: 11829787.


Trehalose extricates impaired mitochondrial and autophagy dysregulation in patient iPSC-derived macular corneal dystrophy disease model.

Nayak D, Shivakumar S, Shetty R, Prashanthi K, Ghosh A, Jeyabalan N Stem Cell Res Ther. 2024; 15(1):464.

PMID: 39639354 PMC: 11622490. DOI: 10.1186/s13287-024-04016-4.


Matrix glycosaminoglycans and proteoglycans in human cornea organoids and similarities with fetal corneal stages.

Ashworth S, Dhanuka M, Khodadadi-Jamayran A, Koduri M, Maiti G, Chakravarti S Ocul Surf. 2024; 35:68-80.

PMID: 39615587 PMC: 11874135. DOI: 10.1016/j.jtos.2024.11.007.


Endoplasmic reticulum stress: molecular mechanism and therapeutic targets.

Chen X, Shi C, He M, Xiong S, Xia X Signal Transduct Target Ther. 2023; 8(1):352.

PMID: 37709773 PMC: 10502142. DOI: 10.1038/s41392-023-01570-w.


Novel compound heterozygous mutations in the gene cause macular corneal dystrophy in a Han Chinese family.

Huang Y, Yuan L, Cao Y, Tang R, Xu H, Tang Z Ann Transl Med. 2021; 9(8):622.

PMID: 33987320 PMC: 8106006. DOI: 10.21037/atm-20-7178.


References
1.
Puthalakath H, OReilly L, Gunn P, Lee L, Kelly P, Huntington N . ER stress triggers apoptosis by activating BH3-only protein Bim. Cell. 2007; 129(7):1337-49. DOI: 10.1016/j.cell.2007.04.027. View

2.
Reed J . Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ. 2006; 13(8):1378-86. DOI: 10.1038/sj.cdd.4401975. View

3.
Kakuta Y, Pedersen L, Pedersen L, Negishi M . Conserved structural motifs in the sulfotransferase family. Trends Biochem Sci. 1998; 23(4):129-30. DOI: 10.1016/s0968-0004(98)01182-7. View

4.
Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot R, Remotti H . CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 1998; 12(7):982-95. PMC: 316680. DOI: 10.1101/gad.12.7.982. View

5.
Weiss J, Moller H, Lisch W, Kinoshita S, Aldave A, Belin M . The IC3D classification of the corneal dystrophies. Cornea. 2009; 27 Suppl 2:S1-83. PMC: 2866169. DOI: 10.1097/ICO.0b013e31817780fb. View